ABBV Stock and Options Trade Setup — AbbVie Inc.
NYSE · S&P 500 · Biopharma & Immunology · High-liquidity options · Large cap · ~$330B
AbbVie executed one of the most difficult patent cliff transitions in pharma history. Humira biosimilar entry was supposed to be existential — instead, Skyrizi and Rinvoq together are growing faster than Humira ever did, with peak sales potential now exceeding $30B combined. The Allergan acquisition added Botox Cosmetic and Therapeutics, Juvederm, and a neuroscience portfolio that diversifies revenue well beyond immunology. AbbVie pays a dividend yielding ~3.5% and has raised it for 12 consecutive years — income funds and dividend ETFs provide structural buying support at every dip. The neuroscience pipeline (ABBV-CLS-7262, emraclidine) adds a speculative upside layer the market hasn't fully priced. With free cash flow approaching $20B annually, buybacks and dividend growth are both sustainable. Options activity shows consistent call buying ahead of quarterly updates, making it a reliable income-plus-directional setup.
Score History & Signal Changelog
Preview dataThis page is a living document — updated every 72 hours from the last scan. Each data point below represents one complete algorithmic snapshot.
Signal Breakdown
Today's Trade Card
Options Profile
Risks & Fundamentals
Every setup carries risk. Here's what could move ABBV against you, plus the key stats that frame any position.
- 1.Skyrizi/Rinvoq facing increasing competition from Eli Lilly's IL-17 and JAK inhibitor pipeline
- 2.Botox Cosmetic demand cyclically sensitive to consumer discretionary spending
- 3.Neuroscience pipeline is high-risk / high-reward — binary readout events create volatility
ABBV Options Setup — Frequently Asked Questions
Is ABBV a good options trade today?+
AbbVie Inc. (ABBV) currently has an Amora Edge Score of 71/100, ranking it top 24% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.
What is ABBV's win rate on Stoptions.ai setups?+
ABBV's historical win rate on closed Stoptions setups is 67%. Win rate is calculated as the percentage of past ABBV trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.
What strike and expiry does Stoptions.ai suggest for ABBV?+
The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.
How often is the ABBV setup updated?+
Every 72 hours we refresh ABBV's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If ABBV drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.
What does the Amora Edge Score measure for ABBV?+
The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to ABBV: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is ABBV outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. ABBV currently scores 71.
How does ABBV compare to other Biopharma & Immunology setups?+
ABBV's sector rank and percentile against other Biopharma & Immunology tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Biopharma & Immunology Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.
Educational content only — not personalized investment advice. Options carry substantial risk.
Get a Friday recap including setups like ABBV.
Every Friday at 4:30 PM ET — trade of the week, signals in motion, sector spotlight, methodology read. 4-minute read. Free.
No spam. One email Friday afternoon. Unsubscribe in one click.